Clinical Study

Neuroimaging Study For Children And Adolescents With Adhd

Posted Date: May 16, 2018

  • Investigator: Melissa Delbello
  • Specialties:
  • Type of Study: Drug

The main purpose of this study is to see the effects of the study medication called MAS-XR on brain function by taking brain pictures. The researchers also want to see if MAS-XR makes your child more or less likely to develop problems like acting out (i.e. aggression). MAS-XR is approved by the U.S. FDA to treat ADHD in adults and in children and adolescents. By completing this study, we hope to better understand how MAS-XR affects brain function. With this information, we hope to be able to improve treatment and clinical outcomes for people with ADHD.


Your Child Is Being Asked To Take Part In This Research Study Because He/She Is 10 To 18 Years Of Age (Inclusive) And Has Been Diagnosed With Adhd (Inattentive, Hyperactive/Impulsive, Or Combined Type) And Is Not Currently Taking A Psychostimulant Medication.


Psychiatry, Adhd, Child, Adolescent

For More Information:

Laura Mclaughlin
(513) 558-6205

  • This contact page is monitored Monday – Friday during business hours, 8 am to 5 pm EST. Do not rely on communication through this website for medical treatment or care. This website is not designed for such purposes.
    For questions regarding clinical studies at UC Health, contact us at or (513) 245-3417.